Related references
Note: Only part of the references are listed.Isavuconazole Population Pharmacokinetic Analysis Using Nonparametric Estimation in Patients with Invasive Fungal Disease (Results from the VITAL Study)
Laura L. Kovanda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent
Marisa H. Miceli et al.
CLINICAL INFECTIOUS DISEASES (2015)
Pharmacokinetic Assessment in Patients Receiving Continuous RRT: Perspectives from the Kidney Health Initiative
Thomas D. Nolin et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases
Seyedmojtaba Seyedmousavi et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2015)
Adherence with Dosing Guideline in Patients with Impaired Renal Function at Hospital Discharge
A. Clara Drenth-van Maanen et al.
PLOS ONE (2015)
Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects
Hamdi Akan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Management of invasive aspergillosis in patients with COPD: rational use of voriconazole
Florence Ader
International Journal of Chronic Obstructive Pulmonary Disease (2012)
Comparative Evaluation of the Cockcroft-Gault Equation and the Modification of Diet in Renal Disease (MDRD) Study Equation for Drug Dosing: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy
Heather A. Nyman et al.
PHARMACOTHERAPY (2011)
Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database
Dimitrios P. Kontoyiannis et al.
CLINICAL INFECTIOUS DISEASES (2010)
Factors Associated with Mortality in Transplant Patients with Invasive Aspergillosis
John W. Baddley et al.
CLINICAL INFECTIOUS DISEASES (2010)
Pharmacokinetics and dosage adjustment in patients with renal dysfunction
Roger K. Verbeeck et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
New generation azole antifungals in clinical investigation
Corrado Girmenia
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault Equations for Dosing Antimicrobials
Elizabeth D. Hermsen et al.
PHARMACOTHERAPY (2009)
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
Altered nonrenal drug clearance in ESRD
Thomas D. Nolin
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2008)
Comparison of dosing recommendations for antimicrobial drugs based on two methods for assessing kidney function: Cockcroft-Gault and modification of diet in renal disease
Monica V. Golik et al.
PHARMACOTHERAPY (2008)
Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy
Federico Pea et al.
CLINICAL PHARMACOKINETICS (2007)
Drug dosage adjustments according to renal function at hospital discharge
Elisabeth A. van Dijk et al.
ANNALS OF PHARMACOTHERAPY (2006)
Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy
RL Trotman et al.
CLINICAL INFECTIOUS DISEASES (2005)
Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence
KH Vandewoude et al.
JOURNAL OF HOSPITAL INFECTION (2004)
Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients
KA Marr et al.
CLINICAL INFECTIOUS DISEASES (2002)
Guided medication dosing for inpatients with renal insufficiency
GM Chertow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
